» Articles » PMID: 38315228

Detection of the DNA Methylation of Seven Genes Contribute to the Early Diagnosis of Lung Cancer

Overview
Specialty Oncology
Date 2024 Feb 5
PMID 38315228
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Low-dose Computed Tomography (CT) is used for the detection of pulmonary nodules, but the ambiguous risk evaluation causes overdiagnosis. Here, we explored the significance of the DNA methylation of 7 genes including TAC1, CDO1, HOXA9, ZFP42, SOX17, RASSF1A and SHOX2 in the blood cfDNA samples in distinguishing lung cancer from benign nodules and healthy individuals.

Method: A total of 149 lung cancer patients [72 mass and 77 ground-glass nodules (GGNs)], 5 benign and 48 healthy individuals were tested and analyzed in this study. The lasso-logistic regression model was built for distinguishing cancer and control/healthy individuals or IA lung cancer and non-IA lung cancer cases.

Results: The positive rates of methylation of 7 genes were higher in the cancer group as compared with the healthy group. We constructed a model using age, sex and the ΔCt value of 7 gene methylation to distinguish lung cancer from benign and healthy individuals. The sensitivity, specificity and AUC (area under the curve) were 86.7%, 81.4% and 0.891, respectively. Also, we assessed the significance of 7 gene methylation together with patients' age and sex in distinguishing of GGNs type from the mass type. The sensitivity, specificity and AUC were 77.1%, 65.8% and 0.753, respectively. Furthermore, the methylation positive rates of CDO1 and SHOX2 were different between I-IV stages of lung cancer. Specifically, the positive rate of CDO1 methylation was higher in the non-IA group as compared with the IA group.

Conclusion: Collectively, this study reveals that the methylation of 7 genes has a big significance in the diagnosis of lung cancer with high sensitivity and specificity. Also, the 7 genes present with certain significance in distinguishing the GGN type lung cancer, as well as different stages.

Citing Articles

Blood-based biomarkers derived from tumor-informed DNA methylation analysis for lung adenocarcinoma.

Chitta P, Barrow T, Dawangpa A, Christiani D, Poungvarin N, Sae-Lee C Heliyon. 2025; 11(4):e42581.

PMID: 40034277 PMC: 11874551. DOI: 10.1016/j.heliyon.2025.e42581.


Epigenetic modifications in early stage lung cancer: pathogenesis, biomarkers, and early diagnosis.

Bi L, Wang X, Li J, Li W, Wang Z MedComm (2020). 2025; 6(3):e70080.

PMID: 39991629 PMC: 11843169. DOI: 10.1002/mco2.70080.


Discrimination of Lung Cancer and Benign Lung Diseases Using BALF Exosome DNA Methylation Profile.

Batochir C, Kim I, Jo E, Kim E, Kim H, Hur J Cancers (Basel). 2024; 16(15).

PMID: 39123492 PMC: 11311347. DOI: 10.3390/cancers16152765.

References
1.
Wrangle J, Machida E, Danilova L, Hulbert A, Franco N, Zhang W . Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer. Clin Cancer Res. 2014; 20(7):1856-64. PMC: 4019442. DOI: 10.1158/1078-0432.CCR-13-2109. View

2.
Li P, Liu S, Du L, Mohseni G, Zhang Y, Wang C . Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer. Clin Epigenetics. 2022; 14(1):118. PMC: 9509651. DOI: 10.1186/s13148-022-01337-0. View

3.
Di Vinci A, Brigati C, Casciano I, Banelli B, Borzi L, Forlani A . HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas. Transl Res. 2012; 160(5):355-62. DOI: 10.1016/j.trsl.2012.05.007. View

4.
Zeng Y, Liu X, Yang W, Zheng P . REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer. Oncogene. 2019; 38(43):6940-6957. DOI: 10.1038/s41388-019-0906-3. View

5.
Magenheim J, Rokach A, Peretz A, Loyfer N, Cann G, Amini H . Universal lung epithelium DNA methylation markers for detection of lung damage in liquid biopsies. Eur Respir J. 2022; 60(5). DOI: 10.1183/13993003.03056-2021. View